Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responsesNature (London), 2020-10, Vol.586 (7830), p.594-599 [Peer Reviewed Journal]Copyright Nature Publishing Group Oct 22, 2020 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-020-2814-7Full text available |
|
2 |
Material Type: Article
|
Post-Vaccination Anti-SARS-CoV-2-Antibody Response in Patients with Multiple Myeloma Correlates with Low CD19+ B-Lymphocyte Count and Anti-CD38 TreatmentCancers, 2021-07, Vol.13 (15), p.3800 [Peer Reviewed Journal]2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers13153800 ;PMID: 34359701Full text available |
|
3 |
Material Type: Article
|
Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemiaBlood, 2021-06, Vol.137 (23), p.3165-3173 [Peer Reviewed Journal]2021 American Society of Hematology ;2021 by The American Society of Hematology. ;2021 by The American Society of Hematology 2021 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2021011568 ;PMID: 33861303Full text available |
|
4 |
Material Type: Article
|
Nonsteroidal Anti-inflammatory Drugs Dampen the Cytokine and Antibody Response to SARS-CoV-2 InfectionJournal of virology, 2021-03, Vol.95 (7) [Peer Reviewed Journal]Copyright © 2021, American Society for Microbiology. All Rights Reserved. ;Copyright © 2021, American Society for Microbiology. All Rights Reserved. 2021 American Society for Microbiology ;ISSN: 0022-538X ;EISSN: 1098-5514 ;DOI: 10.1128/JVI.00014-21 ;PMID: 33441348Full text available |
|
5 |
Material Type: Article
|
Longitudinal dynamics of the human B cell response to the yellow fever 17D vaccineProceedings of the National Academy of Sciences - PNAS, 2020-03, Vol.117 (12), p.6675-6685 [Peer Reviewed Journal]Copyright © 2020 the Author(s). Published by PNAS. ;Copyright National Academy of Sciences Mar 24, 2020 ;Attribution - NonCommercial - NoDerivatives ;Copyright © 2020 the Author(s). Published by PNAS. 2020 ;ISSN: 0027-8424 ;ISSN: 1091-6490 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.1921388117 ;PMID: 32152119Full text available |
|
6 |
Material Type: Article
|
Decreased Antibody Response After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Patients With Down Syndromeinfo:eu-repo/semantics/OpenAccess ;ISSN: 0022-1899 ;EISSN: 1537-6613Full text available |
|
7 |
Material Type: Article
|
SARS-CoV-2 Antibody Response in Persons with Past Natural InfectionNew England Journal of Medicine, 2021-07, Vol.385 (1), p.90-92 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2103825 ;PMID: 33852796Digital Resources/Online E-Resources |
|
8 |
Material Type: Article
|
Dynamics of anti-SARS-CoV-2 IgG antibody responses following breakthrough infection and the predicted protective efficacy: a longitudinal community-based population study in ChinaInternational journal of infectious diseases, 2024-04, p.107075-107075, Article 107075 [Peer Reviewed Journal]2024 ;Copyright © 2024. Published by Elsevier Ltd. ;ISSN: 1201-9712 ;EISSN: 1878-3511 ;DOI: 10.1016/j.ijid.2024.107075 ;PMID: 38697605Full text available |
|
9 |
Material Type: Article
|
SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasmaProceedings of the National Academy of Sciences - PNAS, 2021-09, Vol.118 (36) [Peer Reviewed Journal]Copyright National Academy of Sciences Sep 7, 2021 ;Copyright © 2021 the Author(s). Published by PNAS. 2021 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.2103154118 ;PMID: 34417349Full text available |
|
10 |
Material Type: Article
|
Early-Life Antibiotic-Driven Dysbiosis Leads to Dysregulated Vaccine Immune Responses in MiceCell host & microbe, 2018-05, Vol.23 (5), p.653-660.e5 [Peer Reviewed Journal]2018 Elsevier Inc. ;Copyright © 2018 Elsevier Inc. All rights reserved. ;ISSN: 1931-3128 ;EISSN: 1934-6069 ;DOI: 10.1016/j.chom.2018.04.009 ;PMID: 29746836Full text available |
|
11 |
Material Type: Article
|
Robust neutralizing antibodies to SARS-CoV-2 infection persist for monthsScience, 2020-12, Vol.370 (6521) [Peer Reviewed Journal]2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/science.abd7728Digital Resources/Online E-Resources |
|
12 |
Material Type: Article
|
IgG Against Human Betacoronavirus Spike Proteins Correlates With SARS-CoV-2 Anti-Spike IgG Responses and COVID-19 Disease SeverityThe Journal of infectious diseases, 2022-08, Vol.226 (3), p.474-484 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press for the Infectious Diseases Society of America. 2022 ;The Author(s) 2022. Published by Oxford University Press for the Infectious Diseases Society of America. ;ISSN: 0022-1899 ;EISSN: 1537-6613 ;DOI: 10.1093/infdis/jiac022 ;PMID: 35091739Full text available |
|
13 |
Material Type: Article
|
Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adultsNature medicine, 2022-05, Vol.28 (5), p.1031-1041 [Peer Reviewed Journal]2022. The Author(s), under exclusive licence to Springer Nature America, Inc. ;The Author(s), under exclusive licence to Springer Nature America, Inc. 2022. ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-022-01780-9 ;PMID: 35361992Full text available |
|
14 |
Material Type: Article
|
Virology, transmission, and pathogenesis of SARS-CoV-2BMJ (Online), 2020-10, Vol.371, p.m3862-m3862 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;This article is made freely available for use in accordance with BMJ's website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained. https://bmj.com/coronavirus/usage? ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.m3862 ;PMID: 33097561Full text available |
|
15 |
Material Type: Article
|
The human antibody response to influenza A virus infection and vaccinationNature reviews. Immunology, 2019-06, Vol.19 (6), p.383-397 [Peer Reviewed Journal]COPYRIGHT 2019 Nature Publishing Group ;2019© The Author(s), under exclusive licence to Springer Nature Limited 2019 ;ISSN: 1474-1733 ;EISSN: 1474-1741 ;DOI: 10.1038/s41577-019-0143-6 ;PMID: 30837674Full text available |
|
16 |
Material Type: Article
|
Convergent antibody responses to SARS-CoV-2 in convalescent individualsNature (London), 2020-08, Vol.584 (7821), p.437-442 [Peer Reviewed Journal]COPYRIGHT 2020 Nature Publishing Group ;Copyright Nature Publishing Group Aug 20, 2020 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-020-2456-9 ;PMID: 32555388Full text available |
|
17 |
Material Type: Article
|
Booster dose of SARS-CoV-2 messenger RNA vaccines strengthens the specific immune response of patients with rheumatoid arthritis: A prospective multicenter longitudinal studyInternational journal of infectious diseases, 2022-12, Vol.125, p.195-208 [Peer Reviewed Journal]2022 The Author(s) ;Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved. ;ISSN: 1201-9712 ;EISSN: 1878-3511 ;DOI: 10.1016/j.ijid.2022.10.035 ;PMID: 36328289Full text available |
|
18 |
Material Type: Article
|
Antibody titres decline 3-month post-vaccination with BNT162b2Emerging microbes & infections, 2021-01, Vol.10 (1), p.1495-1498 [Peer Reviewed Journal]2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2021 ;2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2021 The Author(s) ;ISSN: 2222-1751 ;EISSN: 2222-1751 ;DOI: 10.1080/22221751.2021.1953403 ;PMID: 34232116Full text available |
|
19 |
Material Type: Article
|
SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected peopleCell reports (Cambridge), 2022-02, Vol.38 (5), p.110336-110336, Article 110336 [Peer Reviewed Journal]2022 The Author(s) ;Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved. ;2022 The Author(s) 2022 ;ISSN: 2211-1247 ;EISSN: 2211-1247 ;DOI: 10.1016/j.celrep.2022.110336 ;PMID: 35090596Full text available |
|
20 |
Material Type: Article
|
Antibody Response to Omicron BA.4–BA.5 Bivalent BoosterThe New England journal of medicine, 2023-02, Vol.388 (6), p.567-569 [Peer Reviewed Journal]Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2213907 ;PMID: 36630643Full text available |